Tilray Brands Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Tilray Brands Inc trades at $3.6 (market cap $530.54M), while YieldMax Universe Fund of Option Income ETFs trades at $7.53 (market cap $364M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 1,181,378). Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and YieldMax Universe Fund of Option Income ETFs for 55 Days on average.
| TLRY | YMAX | |
|---|---|---|
Market Cap | $530.54M | $364M |
Volume | 9,099,075 | 1,181,378 |
Sector | Health | Income / Options Overlay |
52-Week High | $21.00 | $12.98 |
52-Week Low | $3.57 | $7.27 |
Typical Hold Time | 31 Days | 55 Days |
Enterprise Value | $684.46M | — |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
YMAX trades at $7.53, down 1.83% on the day, with a bearish technical signal from moving averages. The ETF maintains weekly dividend distributions but faces concerns about NAV erosion and sustainability. Recent portfolio adjustments aim to address performance issues, though the fund's structure as a fund-of-funds adds additional cost layers that impact returns.
The outlook remains cautious due to structural concerns and persistent share price decline despite high yield. Investment opportunity exists for income-focused investors willing to accept principal erosion risks, while the primary risk involves unsustainable distribution policy and compounding fees affecting long-term total returns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →